Cognitive-educational treatment of fibromyalgia: A randomized clinical trial .1. Clinical effects

被引:0
|
作者
Vlaeyen, JWS
TeekenGruben, NJG
Goossens, MEJB
RuttenvanMolken, MPMH
Pelt, RAGB
vanEek, H
Heuts, PHTG
机构
[1] LUCAS FDN REHABIL, HOENSBROEK, NETHERLANDS
[2] UNIV LIMBURG, DEPT MED PSYCHOL, 6200 MD MAASTRICHT, NETHERLANDS
[3] UNIV LIMBURG, DEPT HLTH ECON, 6200 MD MAASTRICHT, NETHERLANDS
关键词
fibromyalgia; cognitive-behavioral treatment; group education; pain treatment; psychological treatment; clinical significance;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. This randomized controlled clinical trial evaluates the effectiveness of outpatient group cognitive/educational treatment for patients with the fibromyalgia (FM) syndrome. We hypothesized that the combination of group education with cognitive treatment aimed at developing pain coping skills would be more effective than group education alone. Methods. 131 patients with FM were randomly assigned to 3 conditions: an experimental condition, which was the combined cognitive/educational intervention (ECO); an attention control condition consisting of group education plus group discussion (EDI); and a waiting fist control (WLC). For the treatment conditions ECO and EDI, assessments were made 2 weeks before treatment, at start of treatment, at post-treatment, and at 6 and 12 mo followup. WLC patients received only 3 assessments. Results. There were no pretreatment differences between the groups, or between dropouts and patients who remained in the study. At post-treatment, and compared with the WLC, the ECO patients improved in knowledge about FM (p = 0.007) and pain coping (p < 0.001). EDI patients improved on pain coping (p = 0.005) and pain control (p = 0.002). EDI patients reported significantly less fear than ECO patients (p = 0.005). There were no other differential effects between ECO and EDI at post-treatment or 6 mo or 12 mo followup. Based on the reliability of change index for clinical significance, the relative shea term success rates are 6.4 and 18.4% for ECO and EDI, respectively. Conclusion. The surplus value of a highly structured, 12 session group cognitive treatment added to group education cannot be supported by our study. In EDI, fear reduction might have enhanced pain coping and pain control, while poor compliance, the difficulty of homework assignments, and lack of individual support may have limited the effectiveness of ECO.
引用
收藏
页码:1237 / 1245
页数:9
相关论文
共 50 条
  • [41] Osteopathic medicine for fibromyalgia: a sham-controlled randomized clinical trial
    Coste, Joel
    Medkour, Terkia
    Maigne, Jean-Yves
    Perez, Marc
    Laroche, Francoise
    Perrot, Serge
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [42] Cognitive effects of short-term use of raloxifene: A randomized clinical trial
    Buckwalter, J. G.
    Geiger, A. M.
    Parsons, T. D.
    Handler, J.
    Howes, J.
    Lehmer, R. R.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2007, 117 (11) : 1579 - 1590
  • [43] A PILOT RANDOMIZED CLINICAL TRIAL TO PROMOTE POSITIVE AFFECT IN PATIENTS WITH FIBROMYALGIA
    Reid, Cary
    Ong, Anthony
    Moskowitz, Judy
    Sanni, Mubarak
    Kim, Patricia
    Wethington, Elaine
    Addington, Elizabeth
    Sluys, Erica
    INNOVATION IN AGING, 2022, 6 : 108 - 108
  • [44] The Efficacy of Qigong on the Main Symptoms of Fibromyalgia. A Randomized Clinical Trial
    Sarmento, Caio Vinicius M.
    Pfeifer, Taylor
    Moon, Sanghee
    Maz, Mehrdad
    Lai, Sue Min
    Colgrove, Yvonne
    Smirnova, Irina V.
    Liu, Wen
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2019, 51 (06): : 119 - 119
  • [45] Estimating treatment effects from a randomized clinical trial in the presence of a secondary treatment
    Zhang, Min
    Wang, Yanping
    BIOSTATISTICS, 2012, 13 (04) : 625 - 636
  • [46] Multidisciplinary treatment for fibromyalgia: A randomized trial
    Peloso, PM
    Goodall, K
    Ahmed, N
    Matiko, M
    Lyons, D
    Boyes, D
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S259 - S259
  • [47] Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical trial
    Atzeni, F.
    Casale, R.
    Alciati, A.
    Masala, I. F.
    Batticciotto, A.
    Talotta, R.
    Gerardi, M. C.
    Salaffi, F.
    Sarzi-Puttini, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (01) : S63 - S69
  • [48] Clinical and microbiological effects of the adjunctive use of probiotics in the treatment of gingivitis: A randomized controlled clinical trial
    Montero, Eduardo
    Iniesta, Margarita
    Rodrigo, Marta
    Jose Marin, Maria
    Figuero, Elena
    Herrera, David
    Sanz, Mariano
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2017, 44 (07) : 708 - 716
  • [49] Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial
    Gianferrari, Giulia
    Costantini, Riccardo Cuoghi
    Crippa, Valeria
    Carra, Serena
    Bonetto, Valentina
    Pansarasa, Orietta
    Cereda, Cristina
    Zucchi, Elisabetta
    Martinelli, Ilaria
    Simonini, Cecilia
    Vicini, Roberto
    Fini, Nicola
    Trojsi, Francesca
    Passaniti, Carla
    Ticozzi, Nicola
    Doretti, Alberto
    Diamanti, Luca
    Fiamingo, Giuseppe
    Conte, Amelia
    Dalla Bella, Eleonora
    D'Errico, Eustachio
    Scarian, Eveljn
    Pasetto, Laura
    Antoniani, Francesco
    Galli, Veronica
    Casarotto, Elena
    D'Amico, Roberto
    Poletti, Angelo
    Mandrioli, Jessica
    BRAIN COMMUNICATIONS, 2024, 6 (05)
  • [50] Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial
    Wilkinson, Samuel T.
    Rhee, Taeho Greg
    Joormann, Jutta
    Webler, Ryan
    Lopez, Mayra Ortiz
    Kitay, Brandon
    Fasula, Madonna
    Elder, Christina
    Fenton, Lisa
    Sanacora, Gerard
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2021, 90 (05) : 318 - 327